Controversies in the medical management of breast cancer
- PMID: 3983039
- PMCID: PMC2418174
- DOI: 10.1136/pgmj.61.712.117
Controversies in the medical management of breast cancer
Similar articles
-
Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy.Aust N Z J Surg. 1992 May;62(5):354-63. doi: 10.1111/j.1445-2197.1992.tb07203.x. Aust N Z J Surg. 1992. PMID: 1575655 Review. No abstract available.
-
Adjuvant therapy in early breast cancer.Am Fam Physician. 1991 Aug;44(2):453-62. Am Fam Physician. 1991. PMID: 1858602 Review.
-
Patterns of treatment failure--implications for new treatment approaches.Recent Results Cancer Res. 1989;115:1-7. doi: 10.1007/978-3-642-83337-3_1. Recent Results Cancer Res. 1989. PMID: 2696022 Clinical Trial. No abstract available.
-
Hormonal therapy of breast cancer.Cancer Treat Rev. 1975 Jun;2(2):129-35. doi: 10.1016/s0305-7372(75)80006-5. Cancer Treat Rev. 1975. PMID: 1102087 Review. No abstract available.
-
[Adjuvant medical treatment].Rev Prat. 1990 Apr 1;40(10):905-8. Rev Prat. 1990. PMID: 2183339 Review. French.
Cited by
-
Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Drugs. 1989 Apr;37(4):451-90. doi: 10.2165/00003495-198937040-00004. Drugs. 1989. PMID: 2661195 Review.
-
How Effective is the Treatment of Locally Advanced and Metastatic Breast Cancer in Developing Centres?: A Retrospective Review.Ethiop J Health Sci. 2015 Oct;25(4):337-44. doi: 10.4314/ejhs.v25i4.7. Ethiop J Health Sci. 2015. PMID: 26949298 Free PMC article.
-
Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.Agents Actions. 1987 Dec;22(3-4):324-9. doi: 10.1007/BF02009063. Agents Actions. 1987. PMID: 3445826
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical